Susquehanna Portfolio Strategies, LLC

Position in RLAY — Relay Therapeutics, Inc.

CIK 1996449 Bala Cynwyd, PA

Position in RLAY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,895,154

-$1,478,692 QoQ

Shares Held

101,291

-70.1% QoQ

Ownership

0.046%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#105

of 256 holders

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Susquehanna Portfolio Strategies, LLC holds $399,265,861 across 121 Biotechnology names. RLAY ranks #42 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	90,928	$45,166,665
2	MRNA	Moderna, Inc.	471,043	$32,987,141
3	CORT	Corcept Therapeutics Inc	211,017	$18,347,928
4	BBIO	BridgeBio Pharma, Inc.	226,869	$16,897,203
5	BMRN	Biomarin Pharmaceutical Inc	273,562	$15,653,217
6	HALO	Halozyme Therapeutics, Inc.	166,503	$13,032,189
7	EXEL	Exelixis, Inc.	229,749	$12,500,643
8	MDGL	Madrigal Pharmaceuticals, Inc.	22,003	$11,814,510

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,895,154	101,291	-70.1%	Shares	Sole	2026-08-14
2026-03-31	$3,373,846	339,080	0.0%	Shares	Sole	2026-05-15
2025-12-31	$2,868,616	339,080	0.0%	Shares	Sole	2026-02-17
2025-09-30	$1,769,997	339,080	+42.0%	Shares	Sole	2025-11-14
2025-06-30	$826,296	238,814	+83.7%	Shares	Sole	2025-08-14
2024-09-30	$920,400	130,000	-37.6%	Shares	Defined	2024-11-14
2024-06-30	$1,358,481	208,356	0.0%	Shares	Defined	2024-08-15
2024-03-31	$1,729,354	208,356	-0.8%	Shares	Defined	2024-05-07
2023-12-31	$2,312,133	210,003	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.